Alexza Pharma (ALXA) Resumes, Shares Move Lower
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Alexza Pharma (ALXA) to resume trading at 4:15pm ET
December 21, 2012 3:31 PM ESTAlexza Pharma (NASDAQ: ALXA) to resume trading at 4:15pm EST.... More
FDA Approves Alexza's (ALXA) Adusave
December 21, 2012 3:28 PM ESTAlexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that the U.S. Food and Drug Administration (FDA) approved ADASUVE® (loxapine) Inhalation Powder 10 mg for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults. ADASUVE combines Alexza's proprietary Staccato® delivery system with the antipsychotic drug, loxapine. The Staccato system is a hand-held inhaler that delivers a drug aerosol to the deep lung that results in rapid systemic delivery and absorption of a drug. See below for Important Safety Information about ADASUVE, including Boxed Warnings.
... More
Alexza Pharma (ALXA) trading halted with news pending
December 21, 2012 2:40 PM ESTAlexza Pharma (NASDAQ: ALXA) trading halted with news pending.... More
Sentiment Behind FDA Approval of Alexza's (ALXA) Adusave Improves; Shares Higher Today
December 20, 2012 12:31 PM ESTAlexza Pharmaceuticals (Nasdaq: ALXA) is higher on the session amid positive sentiment behind its Adasuve receiving FDA approval tomorrow.
Last week, Alexza reported that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a... More
